Functional neuroimaging in psychiatry.

Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci (2007) 1.26

White matter neuron alterations in schizophrenia and related disorders. Int J Dev Neurosci (2010) 0.94

Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 0.85

Functional neuroanatomy of executive function after neonatal brain injury in adults who were born very preterm. PLoS One (2014) 0.78

Functional MRI compliance in children with attention deficit hyperactivity disorder. Diagn Interv Radiol (2015) 0.75

Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B (1996) 19.47

Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med (1996) 10.50

Subgenual prefrontal cortex abnormalities in mood disorders. Nature (1997) 9.36

The medial temporal lobe memory system. Science (1991) 7.86

Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science (1998) 7.58

Cingulate function in depression: a potential predictor of treatment response. Neuroreport (1997) 4.48

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry (1986) 4.34

Brain activity during stimulus independent thought. Neuroreport (1996) 4.00

A functional anatomical study of unipolar depression. J Neurosci (1992) 3.85

A functional neuroanatomy of hallucinations in schizophrenia. Nature (1995) 3.78

Remembering the past: two facets of episodic memory explored with positron emission tomography. Am J Psychiatry (1995) 3.71

Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet (1993) 3.42

Neural correlates of self-induced dysphoria. Am J Psychiatry (1993) 2.93

Motor sequence learning: a study with positron emission tomography. J Neurosci (1994) 2.71

Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry (1994) 2.70

Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry (1989) 2.67

The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression. Psychol Med (1992) 2.58

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry (1992) 2.31

Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry (1995) 2.26

A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry (1996) 2.22

Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry (1992) 2.21

Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp (1999) 2.01

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry (1987) 1.98

Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl (1998) 1.92

Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry (1990) 1.92

The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophr Res (1997) 1.79

Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77

Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry (1996) 1.72

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry (1992) 1.70

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet (1997) 1.70

Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry (1988) 1.68

Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med (1993) 1.65

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry (1997) 1.64

Toward a brain map of auditory hallucinations. Am J Psychiatry (1992) 1.59

Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry (1994) 1.57

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry (1989) 1.56

The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry (1997) 1.52

Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry (1995) 1.49

Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry (1993) 1.47

Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport (1995) 1.46

Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry (1989) 1.45

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry (1986) 1.42

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol (1990) 1.41

Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry (1994) 1.40

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry (1985) 1.39

Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci (1996) 1.36

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol (1997) 1.34

Velo-cardio-facial syndrome and psychotic disorders: implications for psychiatric genetics. Am J Med Genet (1994) 1.32

Structural brain abnormalities in male schizophrenics reflect fronto-temporal dissociation. Psychol Med (1997) 1.32

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry (1982) 1.30

Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry (1996) 1.29

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry (1996) 1.27

The neural correlates of inner speech and auditory verbal imagery in schizophrenia: relationship to auditory verbal hallucinations. Br J Psychiatry (1996) 1.24

Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology (1989) 1.23

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23

Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging. Arch Gen Psychiatry (1998) 1.22

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord (1986) 1.20

A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry (1995) 1.20

Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology (1992) 1.14

Changes in regional cerebral blood flow on recovery from depression. Psychol Med (1995) 1.13

Distribution of cerebral activity in chronic schizophrenia. Lancet (1974) 1.13

Functional anatomy of calorie fear in anorexia nervosa. Lancet (1998) 1.11

Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? J Neurol Neurosurg Psychiatry (1993) 1.11

Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry (1998) 1.10

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry (1992) 1.08

Depression in Parkinson's disease. A positron emission study. Br J Psychiatry (1994) 1.05

Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics. Arch Gen Psychiatry (1985) 1.05

Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry (1992) 1.05

Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci (1994) 1.04

Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry (1997) 1.03

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Arch Gen Psychiatry (1984) 1.02

Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry (1983) 0.99

Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry (1990) 0.98

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology (1997) 0.96

Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci (1996) 0.93

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry (1985) 0.93

Regional brain function in schizophrenia. I. A positron emission tomography study. Arch Gen Psychiatry (1987) 0.93

The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Arch Gen Psychiatry (1997) 0.93

Pathophysiology of 'positive' thought disorder in schizophrenia. Br J Psychiatry (1998) 0.92

15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet (1984) 0.92

Brain function in psychiatric disorders. II. Regional cerebral blood flow in medicated unipolar depressives. Arch Gen Psychiatry (1984) 0.92

Neuroanatomical correlates of anticipatory anxiety. Science (1989) 0.92

PET images of blood flow changes during anxiety: correction. Science (1992) 0.92

Patterns of metabolic activity in the treatment of schizophrenia. Ann Neurol (1984) 0.91

Regional cerebral blood flow and cognitive function in Huntington's disease and schizophrenia. A comparison of patients matched for performance on a prefrontal-type task. Arch Neurol (1990) 0.90

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol Psychiatry (1987) 0.89

Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry (1988) 0.89

Attenuated frontal activation in schizophrenia may be task dependent. Schizophr Res (1999) 0.89

Functional neuroanatomy of visually elicited simple phobic fear: additional data and theoretical analysis. Psychophysiology (1995) 0.89

Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder. An evolving perspective on brain and behaviour. Br J Psychiatry Suppl (1998) 0.89

Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc Natl Acad Sci U S A (1987) 0.88

Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia. Br J Psychiatry (1998) 0.88

Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients. Biol Psychiatry (1993) 0.88

Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiatry Res (1997) 0.87

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. Arch Gen Psychiatry (1987) 0.87

Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord (1992) 0.86

PET studies of glucose metabolism in patients with schizophrenia. AJNR Am J Neuroradiol (1983) 0.86

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psychiatry (1988) 0.86

Regional cerebral blood flow in schizophrenia. Arch Gen Psychiatry (1982) 0.86

Regional cerebral glucose metabolism in major depressive disorder. Can J Psychiatry (1990) 0.85

Activation of auditory cortex during silent lipreading. Science (1997) 3.94

Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry (2000) 2.93

A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage (1995) 2.58

Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp (1999) 2.01

Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis. Neurosci Biobehav Rev (2010) 1.65

Grey matter correlates of syndromes in schizophrenia. A semi-automated analysis of structural magnetic resonance images. Br J Psychiatry (1997) 1.47

Disordered functional connectivity in schizophrenia. Psychol Med (1996) 1.45

Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study. Arch Gen Psychiatry (2001) 1.38

Altered connections on the road to psychopathy. Mol Psychiatry (2009) 1.38

Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. Am J Psychiatry (1997) 1.38

Common and distinct neural substrates for pragmatic, semantic, and syntactic processing of spoken sentences: an fMRI study. J Cogn Neurosci (2000) 1.35

Delusion formation and reasoning biases in those at clinical high risk for psychosis. Br J Psychiatry Suppl (2007) 1.35

The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review. Curr Pharm Des (2009) 1.31

Auditory hallucinations: a review of psychological treatments. Schizophr Res (1998) 1.30

Mapping of grey matter changes in schizophrenia. Schizophr Res (1999) 1.27

Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry (2012) 1.25

A functional study of auditory verbal imagery. Psychol Med (2001) 1.21

Supra-regional brain systems and the neuropathology of schizophrenia. Cereb Cortex (1999) 1.21

Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci Biobehav Rev (2012) 1.14

Reduced sensitivity to linguistic context in schizophrenic thought disorder: evidence from on-line monitoring for words in linguistically anomalous sentences. J Abnorm Psychol (1998) 1.14

Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry (1998) 1.10

Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. Arch Gen Psychiatry (2011) 1.09

Verbal self-monitoring and auditory verbal hallucinations in patients with schizophrenia. Psychol Med (2001) 1.08

Economic impact of early intervention in people at high risk of psychosis. Psychol Med (2009) 1.05

Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. J Affect Disord (2001) 1.04

Effect of symptoms on executive function in bipolar illness. Psychol Med (2004) 1.01

The brain in obsessive-compulsive disorder. J Neurol Neurosurg Psychiatry (1995) 1.00

A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med (2000) 1.00

Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des (2012) 0.98

Effect of disrupted-in-schizophrenia-1 on pre-frontal cortical function. Mol Psychiatry (2008) 0.97

Differential activation of temporal cortex during sentence completion in schizophrenic patients with and without formal thought disorder. Schizophr Res (2001) 0.96

A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res (2000) 0.95

Sensitivity to linguistic anomalies in spoken sentences: a case study approach to understanding thought disorder in schizophrenia. Psychol Med (2000) 0.94

Modality specific neural correlates of auditory and somatic hallucinations. J Neurol Neurosurg Psychiatry (2001) 0.94

Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state: a latent class cluster analysis study. Psychol Med (2013) 0.93

Reversed lateralization of temporal activation during speech production in thought disordered patients with schizophrenia. Psychol Med (2002) 0.93

Engagement of right temporal cortex during processing of linguistic context. Neuropsychologia (2001) 0.92

Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function. Mol Psychiatry (2012) 0.92

Dispersed activation in the left temporal cortex for speech-reading in congenitally deaf people. Proc Biol Sci (2001) 0.92

The role of metacognitive beliefs in determining the impact of anomalous experiences: a comparison of help-seeking and non-help-seeking groups of people experiencing psychotic-like anomalies. Psychol Med (2008) 0.90

Aeromonas hydrophila bacteremia acquired from an infected swimming pool. Clin Infect Dis (1999) 0.90

Attenuated frontal activation in schizophrenia may be task dependent. Schizophr Res (1999) 0.89

Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study. J Am Acad Child Adolesc Psychiatry (2001) 0.89

Verbal self-monitoring and auditory hallucinations in schizophrenia. Lancet (1999) 0.88

Radiological findings in individuals at high risk of psychosis. J Neurol Neurosurg Psychiatry (2006) 0.87

Schizotypy and brain structure: a voxel-based morphometry study. Psychol Med (2009) 0.87

Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. Eur Neuropsychopharmacol (2007) 0.86

Longitudinal follow-up of cavum septum pellucidum and adhesio interthalamica alterations in first-episode psychosis: a population-based MRI study. Psychol Med (2012) 0.85

Neural correlates of visuospatial working memory in the 'at-risk mental state'. Psychol Med (2010) 0.85

Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment. Psychol Med (2010) 0.84

Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychol Med (2010) 0.83

Delusional ideation, manic symptomatology and working memory in a cohort at clinical high-risk for psychosis: a longitudinal study. Eur Psychiatry (2010) 0.83

Interpersonal sensitivity in the at-risk mental state for psychosis. Psychol Med (2012) 0.82

No association of Disrupted-in-Schizophrenia-1 variation with prefrontal function in patients with schizophrenia and bipolar disorder. Genes Brain Behav (2010) 0.82

Is auditory imagery defective in patients with auditory hallucinations? Psychol Med (2000) 0.81

Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation. Pharmacopsychiatry (2010) 0.79

Affective modulation of external misattribution bias in source monitoring in schizophrenia. Psychol Med (2008) 0.79

Regional variation of cloze probabilities for sentence contexts. Behav Res Methods Instrum Comput (2001) 0.79

Neural correlates of movement generation in the 'at-risk mental state'. Acta Psychiatr Scand (2010) 0.79

The corpus callosum and empathy in adults with a history of preterm birth. J Int Neuropsychol Soc (2010) 0.78

Lexical retrieval during fluent speech production: an fMRI study. Neuroreport (2000) 0.78

Faulty suppression of irrelevant material in patients with thought disorder linked to attenuated frontotemporal activation. Schizophr Res Treatment (2012) 0.77

Delta-9-tetrahydrocannabinol disruption of time perception and of self-timed actions. Pharmacopsychiatry (2010) 0.76

Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review. Curr Pharm Des (2014) 0.76

The size and prevalence of the cavum septum pellucidum are normal in subjects with panic disorder. Braz J Med Biol Res (2004) 0.75

[OASIS (Outreach And Support in South London), evaluation and treatment of adolescents and young adults at "high risk" of developing a psychotic disorder]. Encephale (2008) 0.75